Efficacy evaluation of Bauhinia variegata L. stem bark powder as adjunct therapy in chronic Staphylococcus aureus mastitis in goat

ABSTRACT

Objective: The objective was to study the effect of Bauhinia variegata L. stem bark powder as adjunct therapy in chronic Staphylococcus aureus mastitis in goat. Materials and Methods: Mastitis was induced by intracisternal inoculation of coagulase positive S. aureus (J638) at the concentration of 2000 colony forming units. Group I animals were treated with repeated dose of ceftriaxone at 20 mg/kg intravenously, and Group II animals were treated with once daily oral administration of B. variegata L. stem bark powder at 6 g/kg for 7 days followed by maintenance dose at 3 g/kg for next 7 days along with repeated dose of the antibiotic at 20 mg/kg intravenously at 4 days interval. Results: No significant improvement in the clinical condition of the udder was noticed in the group treated with repeated dose of ceftriaxone alone. However, in the group treated with B. variegata L. stem bark powder along with repeated dose of ceftriaxone, no S. aureus colony was seen at 96 h and onwards in milk samples with a marked decrease in somatic cell count and milk alkaline phosphatase activity and increased lactoperoxidase activity. Further, plasma and milk concentration of ceftriaxone/ceftizoxime was increased, which indicated antibacterial, bioenhancing and antiinflammatory properties of the bark powder. The Group II animals also exhibited marked reduction in polymorphonuclear cells and fibrous tissue indicating antifibrotic property of B. variegata L. Conclusion: B. variegata L. stem bark powder can be considered as an effective adjunct therapy to intravenous ceftriaxone in S. aureus chronic mastitis in goat.

KEYWORDS

• Bauhinia variegata L
• ceftriaxone
• chronic mastitis
• goat
• Staphylococcus aureus

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.4103/0973-1296.139786Copy

RELATED ARTICLES

Matched on volume, issue, section and article type within Pharmacogn. Mag..

• Article · VOLUME 10, ISSUE 39Anticancer activity of cissampelos pareira against dalton’s lymphoma ascites bearing miceB. Samuel Thavamani, Molly Mathew, S. P. Dhanabal · pp. 200–206ORIGINAL ARTICLESame type: ArticleSame issue
• Article · VOLUME 10, ISSUE 39Effects of rhamnocitrin 4‑β‑D‑galactopyranoside, isolated from Astragalus hamosus on toxicity models in vitroMagdalena Kondeva‑Burdina, Ilina Krasteva, Mitka Mitcheva · pp. S487–S492ORIGINAL ARTICLESame type: ArticleSame issue
• Article · VOLUME 10, ISSUE 39The Pavonia xanthogloea (Ekman, Malvaceae): Phenolic compounds quantification, anti‑oxidant and cytotoxic effect on human lymphocytes cellsClarice Pinheiro Mostardeiro, Marco Aurélio Mostardeiro, Ademir Farias Morel, Raul Moreira Oliveira, Alencar Kolinski Machado, Pauline Ledur, Francine Carla Cadoná, Ubiratan Flores da Silva, Ivana Beatrice Mânica da Cruz · pp. S630–S637ORIGINAL ARTICLESame type: ArticleSame issue
• Article · VOLUME 10, ISSUE 40Classification and quantification analysis of peach kernel from different origins with near-infrared diffuse reflection spectroscopyWei Liu, Zhen-Zhong Wang, Jian-Ping Qing, Hong-Juan Li, Wei Xiao · pp. 441–442ORIGINAL ARTICLESame type: ArticleVolume 10